ACCELERON PHARMA INC 4/A SEC Filings

Filed On	Filing
02 Feb 2021	Form 4/A: Kango Sujay, EVP, Chief Commercial Officer Received 10,000 shares by exercise or conversion ($406K)
10 Feb 2020	Form 4/A: Backstrom Jay T., EVP, Research and Development Granted 96,963 Option to Purchase Common Stock
10 Feb 2020	Form 4/A: Malik Kemal, Director Granted 17,956 Option to Purchase Common Stock
08 Mar 2017	Form 4/A: Mcguire Terrance, Director Holds 0 shares of Common Stock
08 Mar 2017	Form 4/A: Mcguire Terrance, Director Holds 0 shares of Common Stock
26 Aug 2015	Form 4/A: Mcguire Terrance, Director Sold 407,259 shares ($12.3M)
03 Jun 2015	Form 4/A: Mcguire Terrance, Director Disposed of 407,256 shares (Other Transaction)
03 Jun 2015	Form 4/A: Mcguire Terrance, Director Disposed of 503,991 shares (Other Transaction)
08 Apr 2015	Form 4/A: Kearney Terrence C, Director Granted 4,665 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: Nader Francois, Director Granted 576 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: Pops Richard F, Director Granted 10,000 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: Zakrzewski Joseph S, Director Granted 10,000 Option to purchase Common Stock
08 Apr 2015	Form 4/A: Maniatis Tom, Director Granted 10,000 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: George Jean, Director Granted 10,000 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: Mcguire Terrance, Director Granted 10,000 Option to Purchase Common Stock
08 Apr 2015	Form 4/A: Kania Edwin M Jr, Director Granted 10,000 Option to Purchase Common Stock
15 Dec 2014	Form 4/A: Mcguire Terrance, Director and 3 others Disposed of 198,005 shares (Other Transaction)
12 Dec 2014	Form 4/A: Sherman Matthew L, SVP & Chief Medical Officer Sold 2,000 shares ($63K)
02 Dec 2014	Form 4/A: Kumar Ravindra, VP & Chief Scientific Officer Exercised 2,000 Option to Purchase Common Stock

Comments